-
Preparing to discharge a frail, elderly patient is a task that shouldn't be taken lightly in any setting, but for Priscilla F. Cutler, MSW, LICSW, MFA, ensuring that an elderly patient's safety net is in place can prove challenging in a mountainous, lightly populated area of New Hampshire.
-
Medicare providers by now should have begun using the revised advance beneficiary notice (ABN) of coverage to let participants know when Medicare is unlikely to cover their care.
-
The Joint Commission in 2006 initiated a new standard that demands "accurate and complete reconciliation of medications across the continuum of care," but nurses and case managers at Mercy Health Center in Oklahoma City were way ahead of them. Long troubled by discrepancies in patients' in-hospital and at-home medications, they already had a solution in the works.
-
Sometimes the bright light of unwanted attention can spur improvement, and that's the theory behind the Centers for Medicare & Medicaid Services' (CMS) decision to publish the names of underperforming nursing homes.
-
The Centers for Medicare and Medicaid Services (CMS) has created a free brochure outlining the five levels of the Medicare Part A and Part B appeals process. The overview describes the process and provides details on where to get more information about Medicare appeals.
-
Clinicians are becoming more attuned to the many complications of influenza, particularly with the high morbidity and mortality seen with H5N1 strains spreading around the world.
-
In This Issue: FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Eight hiv-infected patients (mean CD4+ t cell count 622 cells/uL) who had been receiving effective HAART for an average of 8.4 years were included in this study. PBMCs were obtained by leukapheresis and endoscopic terminal ileum biopsies were performed to obtain samples of Gut-Associated Lymphoid Tissue (GALT).
-
In 1985, the newly fda-approved antimicrobial agent, Primaxin® (imipenem/cilastatin), introduced a new class of drugs known as carbapenems. This new class provided benefits as well as unwanted side effects. Carbapenems work similarly to other â-lactam antibiotics, but with substantially broader-spectrum of activity and better penetration into bacterial cell walls to prevent synthesis.
-
Trauma in wartime is especially high risk given the nature of the injuries, the high risk of infection, and the limited access to optimal medical care.
